ATRA vs CNC · rev $128.9M vs P/E 8.4, rev $163.07B
Atara Biotherapeutics Inc (ATRA) versus Centene Corp (CNC) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Centene Corp (CNC) is a healthcare plans company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
ATRA currently screens at market cap $87.1M. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Not investment advice. Open the ATRA and CNC stock pages for the full models.
Not investment advice.